New London, CT, United States of America

Yu Hui

This inventor holds 1 USPTO granted patent. Top assignee: Wyeth. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu Hui. Retrieved from https://idiyas.com/inventor/yu-hui-80slpz21

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yu Hui in the Field of Therapeutics.

Introduction

Yu Hui is an accomplished inventor based in New London, CT (US). He has made significant contributions to the field of therapeutics, particularly in the development of compounds that target specific diseases.

Latest Patents

Yu Hui holds a patent for "Diphenylimidazopyrimidines as inhibitors of β-secretase." This invention provides a compound of formula I and outlines its use for the therapeutic treatment, prevention, or amelioration of diseases characterized by elevated β-amyloid deposits or β-amyloid levels in patients. His innovative approach addresses critical health issues related to neurodegenerative disorders.

Career Highlights

Yu Hui is associated with Wyeth, a prominent company in the pharmaceutical industry. His work at Wyeth has allowed him to focus on groundbreaking research and development in the field of therapeutics.

Collaborations

Yu Hui has collaborated with notable colleagues, including Michael Sotirios Malamas and James Joseph Erdei. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Yu Hui's contributions to the field of therapeutics through his innovative patent demonstrate his commitment to addressing significant health challenges. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…